Compound Detail
CHEMBL404039
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
Basic Information
| ChEMBL ID | CHEMBL404039 |
| Phase | Preclinical |
| Structure Type | MOL |
| InChI Key | VXXORYZRZBKIKG-UHFFFAOYSA-N |
1
Targets
1
Activities
1
Assay Types
0
PK Parameters
1
Publications
0
Known Names
Molecular Properties
266.7
MW (Da)
3.05
ALogP
1
HBA
2
HBD
44.9
PSA (Ų)
0.88
QED
0
Ro5 Violations
3
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| Availability | Unknown |
| Chirality | Unknown |
Activity Summary
EC50 1 meas. best 5.31
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| Jurkat CHEMBL397 | EC50 | 5.31 | 5.31 | 4900.0 | 1 |
Activity Data Samples
Top measurements by pChEMBL value
| Target | Type | Rel. | Value | Units | pChEMBL | Assay | PubMed |
|---|---|---|---|---|---|---|---|
| Jurkat | EC50 | = | 4900.0 | nM | 5.31 | Inhibition of TNF-alpha-induced necroptosis in FADD-deficient human Jurkat T cel... | 18467094 |
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 18467094 | 10.1016/j.bmcl.2008.04.048 | Jurkat | 1 |
Data from ChEMBL 36 via Core Engine